Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 45.53%218.86M | 45.53%218.86M | -9.60%150.39M | 63.36%298.67M | --317.39M | -7.95%150.39M | --150.39M | --166.36M | --182.83M | 338.23%163.37M |
-Cash and cash equivalents | -50.60%74.29M | -50.60%74.29M | 6.39%150.39M | 89.23%298.67M | --317.39M | -7.95%150.39M | --150.39M | --141.36M | --157.83M | 338.23%163.37M |
-Short-term investments | --144.57M | --144.57M | ---- | ---- | ---- | --0 | --0 | --25M | --25M | ---- |
Receivables | -34.30%500K | -34.30%500K | -30.12%761K | 190.70%750K | --875K | 52.20%761K | --761K | --1.09M | --258K | 100.00%500K |
-Taxes receivable | -34.30%500K | -34.30%500K | 20.22%761K | 190.70%750K | --875K | 52.20%761K | --761K | --633K | --258K | 100.00%500K |
-Other receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --456K | ---- | ---- |
Prepaid assets | -13.63%7.62M | -13.63%7.62M | -29.63%8.82M | -41.70%9.09M | --9.21M | -52.97%8.82M | --8.82M | --12.53M | --15.59M | 245.81%18.75M |
Total current assets | 41.89%226.98M | 41.89%226.98M | -11.12%159.97M | 55.28%308.51M | --327.48M | -12.40%159.97M | --159.97M | --179.98M | --198.69M | 325.18%182.62M |
Non current assets | ||||||||||
Net PPE | -47.08%154K | -47.08%154K | 561.36%291K | 188.16%219K | --250K | 109.35%291K | --291K | --44K | --76K | --139K |
-Gross PPE | -47.08%154K | -47.08%154K | 561.36%291K | 188.16%219K | --250K | 109.35%291K | --291K | --44K | --76K | --139K |
Investments and advances | --47.68M | --47.68M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Non current deferred assets | --0 | --0 | 44.40%2.73M | --0 | --0 | --2.73M | --2.73M | --1.89M | ---- | --0 |
Other non current assets | 17.76%126K | 17.76%126K | 50.70%107K | 52.44%125K | --108K | 48.61%107K | --107K | --71K | --82K | -17.24%72K |
Total non current assets | 1,432.36%47.96M | 1,432.36%47.96M | 55.95%3.13M | 117.72%344K | --358K | 1,383.41%3.13M | --3.13M | --2.01M | --158K | 142.53%211K |
Total assets | 68.57%274.94M | 68.57%274.94M | -10.38%163.1M | 55.33%308.86M | --327.84M | -10.79%163.1M | --163.1M | --181.99M | --198.84M | 324.81%182.83M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -16.55%3.78M | -16.55%3.78M | -5.94%4.53M | -40.97%3.81M | --4.1M | 46.48%4.53M | --4.53M | --4.82M | --6.46M | 955.97%3.09M |
-accounts payable | -16.55%3.78M | -16.55%3.78M | -5.94%4.53M | -40.97%3.81M | --4.1M | 46.48%4.53M | --4.53M | --4.82M | --6.46M | 955.97%3.09M |
Current accrued expenses | 154.71%9.17M | 154.71%9.17M | 31.11%3.6M | 31.98%6.1M | --4.7M | 46.24%3.6M | --3.6M | --2.75M | --4.62M | 302.12%2.46M |
Current debt and capital lease obligation | 15.71%162K | 15.71%162K | 218.18%140K | 100.00%152K | --147K | 9.38%140K | --140K | --44K | --76K | --128K |
-Current capital lease obligation | 15.71%162K | 15.71%162K | 218.18%140K | 100.00%152K | --147K | 9.38%140K | --140K | --44K | --76K | --128K |
Current liabilities | 48.61%17.27M | 48.61%17.27M | 15.09%11.62M | -5.58%12.1M | --9.98M | 39.04%11.62M | --11.62M | --10.1M | --12.81M | 359.85%8.36M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -92.09%14K | -92.09%14K | --177K | --98K | --138K | 1,509.09%177K | --177K | --0 | --0 | --11K |
-Long term capital lease obligation | -92.09%14K | -92.09%14K | --177K | --98K | --138K | 1,509.09%177K | --177K | --0 | --0 | --11K |
Preferred securities outside stock equity | --0 | --0 | 0.00%304.49M | --0 | --0 | 17.31%304.49M | --304.49M | --304.49M | ---- | --259.57M |
Total non current liabilities | -100.00%14K | -100.00%14K | 0.06%304.67M | --98K | --138K | 17.37%304.67M | --304.67M | --304.49M | --0 | --259.58M |
Total liabilities | -94.53%17.29M | -94.53%17.29M | 0.54%316.29M | -4.82%12.2M | --10.12M | 18.04%316.29M | --316.29M | --314.59M | --12.81M | 14,638.28%267.94M |
Shareholders'equity | ||||||||||
Share capital | --3K | --3K | --0 | -100.00%3K | --3K | --0 | --0 | --0 | --304.49M | --0 |
-common stock | --3K | --3K | --0 | -25.00%3K | --3K | --0 | --0 | --0 | --4K | --0 |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- | --304.49M | ---- |
Retained earnings | -50.99%-238.33M | -50.99%-238.33M | -15.51%-157.85M | -61.26%-197.14M | ---175.26M | -78.33%-157.85M | ---157.85M | ---136.65M | ---122.25M | -71.51%-88.51M |
Paid-in capital | 10,566.27%496.2M | 10,566.27%496.2M | 11.99%4.65M | 12,935.69%493.79M | --492.98M | 36.70%4.65M | --4.65M | --4.15M | --3.79M | 14.81%3.4M |
Gains losses not affecting retained earnings | ---211K | ---211K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other equity interest | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---106K | ---- | ---- |
Total stockholders'equity | 268.19%257.65M | 268.19%257.65M | -15.53%-153.19M | 59.47%296.66M | --317.72M | -80.00%-153.19M | ---153.19M | ---132.6M | --186.03M | -306.47%-85.11M |
Total equity | 268.19%257.65M | 268.19%257.65M | -15.53%-153.19M | 59.47%296.66M | --317.72M | -80.00%-153.19M | ---153.19M | ---132.6M | --186.03M | -306.47%-85.11M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion with Explanatory Notes |